tetano
Editor, Senior Moderator
Pediatr Blood Cancer
. 2022 Apr 5;e29707.
doi: 10.1002/pbc.29707. Online ahead of print.
Factors affecting COVID-19 vaccine hesitancy in parents of children with cancer
Micah A Skeens[SUP] 1 [/SUP], Kylie Hill[SUP] 1 [/SUP], Anna Olsavsky[SUP] 1 [/SUP], Kimberly Buff[SUP] 2 [/SUP], Jack Stevens[SUP] 1 [/SUP], Terrah Foster Akard[SUP] 3 [/SUP], Nilay Shah[SUP] 4 5 [/SUP], Cynthia A Gerhardt[SUP] 1 [/SUP]
Affiliations
Abstract
Aim: Little research exists on coronavirus (COVID-19) vaccine hesitancy among caregivers of children with cancer. We aimed to (a) describe vaccine hesitancy in parents of children with cancer for both their child and self, and (b) examine the mediating role of parent-reported COVID impact on the association between COVID exposure and vaccine hesitancy.
Procedure: We conducted a national survey of parents of children with cancer via Facebook and Momcology, a pediatric cancer community-based organization recruited February-May 2021. Parents completed standardized measures online. A series of mediation models assessed the role of COVID-19 impact (e.g., effects on parenting and well-being) on associations between COVID-19 exposure (e.g., direct/indirect exposure) and vaccine hesitancy. Moderation models examined the role of treatment status, COVID-19 exposure, impact, and vaccine hesitancy.
Results: Parents (n = 491; 90% mothers; 93% White) reported moderate vaccine hesitancy (M = 2.08, SD = 0.76). Specifically, 18.5% (n = 90) reported they would not vaccinate their child, and 24.4% (n = 119) would only consider vaccination. Parents expressed higher concerns about vaccine side effects for their children (M = 3.01, SD = 0.95) than for themselves (M = 2.61, SD = 1.03; t[479] = 9.07, p < .01). Mediation analysis revealed a significant indirect effect of impact (95% CI [-0.013, -0.001]) on the association between higher exposure and higher vaccine hesitancy (b = .02, p = .06). There was no moderating effect of treatment status. Income remained a significant covariate (b = -.11, p < .01).
Conclusion: Lower parent-reported COVID exposure, higher COVID impact, concern for side effects, and lower income may be important factors related to vaccine hesitancy among parents of children with cancer. Providers of childhood cancer survivors should address vaccine hesitancy and potential health risks.
Keywords: COVID-19; childhood cancer; vaccine hesitancy.
. 2022 Apr 5;e29707.
doi: 10.1002/pbc.29707. Online ahead of print.
Factors affecting COVID-19 vaccine hesitancy in parents of children with cancer
Micah A Skeens[SUP] 1 [/SUP], Kylie Hill[SUP] 1 [/SUP], Anna Olsavsky[SUP] 1 [/SUP], Kimberly Buff[SUP] 2 [/SUP], Jack Stevens[SUP] 1 [/SUP], Terrah Foster Akard[SUP] 3 [/SUP], Nilay Shah[SUP] 4 5 [/SUP], Cynthia A Gerhardt[SUP] 1 [/SUP]
Affiliations
- PMID: 35384278
- DOI: 10.1002/pbc.29707
Abstract
Aim: Little research exists on coronavirus (COVID-19) vaccine hesitancy among caregivers of children with cancer. We aimed to (a) describe vaccine hesitancy in parents of children with cancer for both their child and self, and (b) examine the mediating role of parent-reported COVID impact on the association between COVID exposure and vaccine hesitancy.
Procedure: We conducted a national survey of parents of children with cancer via Facebook and Momcology, a pediatric cancer community-based organization recruited February-May 2021. Parents completed standardized measures online. A series of mediation models assessed the role of COVID-19 impact (e.g., effects on parenting and well-being) on associations between COVID-19 exposure (e.g., direct/indirect exposure) and vaccine hesitancy. Moderation models examined the role of treatment status, COVID-19 exposure, impact, and vaccine hesitancy.
Results: Parents (n = 491; 90% mothers; 93% White) reported moderate vaccine hesitancy (M = 2.08, SD = 0.76). Specifically, 18.5% (n = 90) reported they would not vaccinate their child, and 24.4% (n = 119) would only consider vaccination. Parents expressed higher concerns about vaccine side effects for their children (M = 3.01, SD = 0.95) than for themselves (M = 2.61, SD = 1.03; t[479] = 9.07, p < .01). Mediation analysis revealed a significant indirect effect of impact (95% CI [-0.013, -0.001]) on the association between higher exposure and higher vaccine hesitancy (b = .02, p = .06). There was no moderating effect of treatment status. Income remained a significant covariate (b = -.11, p < .01).
Conclusion: Lower parent-reported COVID exposure, higher COVID impact, concern for side effects, and lower income may be important factors related to vaccine hesitancy among parents of children with cancer. Providers of childhood cancer survivors should address vaccine hesitancy and potential health risks.
Keywords: COVID-19; childhood cancer; vaccine hesitancy.